Mechanisms of Gut Homeostasis Regulating Th17/Treg Cell Balance in PMOP

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2024 Dec 30

PMID 39735544

Authors

Peng Qi

Ruixuan Xie

Hao Liu

Zixuan Zhang

Yuan Cheng

Jilong Ma

Kangwei Wan

XingWen Xie

Affiliations

Soon will be listed here.

Abstract

Postmenopausal osteoporosis (PMOP) is a metabolic bone disease driven by estrogen deficiency, primarily manifesting as reduced bone mass and heightened fracture risk. Its development is intricately linked to the balance between Th17 and Treg cells. Recent studies have highlighted the significant role of gut homeostasis in PMOP. The gut microbiota profoundly impacts bone health by modulating the host's immune system, metabolic pathways, and endocrine functions. In particular, the regulation of Th17 and Treg cell balance by gut homeostasis plays a pivotal role in the onset and progression of PMOP. Th17 cells secrete pro-inflammatory cytokines that stimulate osteoclast activity, accelerating bone resorption, while Treg cells counteract this process through anti-inflammatory mechanisms, preserving bone mass. The gut microbiota and its metabolites can influence Th17/Treg equilibrium, thereby modulating bone metabolism. Furthermore, the integrity of the gut barrier is critical for systemic immune stability, and its disruption can lead to immune dysregulation and metabolic imbalances. Thus, targeting gut homeostasis to restore Th17/Treg balance offers a novel therapeutic avenue for the prevention and treatment of PMOP.

References

Zhao T, Wei Y, Zhu Y, Xie Z, Hai Q, Li Z . Gut microbiota and rheumatoid arthritis: From pathogenesis to novel therapeutic opportunities. Front Immunol. 2022; 13:1007165. PMC: 9499173. DOI: 10.3389/fimmu.2022.1007165. View

Liu L, Liang L, Liang H, Wang M, Lu B, Xue M . Aggravates the Progression of Colitis by Regulating M1 Macrophage Polarization via AKT2 Pathway. Front Immunol. 2019; 10:1324. PMC: 6582778. DOI: 10.3389/fimmu.2019.01324. View

Lucas S, Omata Y, Hofmann J, Bottcher M, Iljazovic A, Sarter K . Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss. Nat Commun. 2018; 9(1):55. PMC: 5754356. DOI: 10.1038/s41467-017-02490-4. View

Keita A, Soderholm J . The intestinal barrier and its regulation by neuroimmune factors. Neurogastroenterol Motil. 2010; 22(7):718-33. DOI: 10.1111/j.1365-2982.2010.01498.x. View

Rosser E, Piper C, Matei D, Blair P, Rendeiro A, Orford M . Microbiota-Derived Metabolites Suppress Arthritis by Amplifying Aryl-Hydrocarbon Receptor Activation in Regulatory B Cells. Cell Metab. 2020; 31(4):837-851.e10. PMC: 7156916. DOI: 10.1016/j.cmet.2020.03.003. View

Schoultz I, Keita A . The Intestinal Barrier and Current Techniques for the Assessment of Gut Permeability. Cells. 2020; 9(8). PMC: 7463717. DOI: 10.3390/cells9081909. View

Zhang Z, Zhang X, Zhao D, Liu B, Wang B, Yu W . TGF‑β1 promotes the osteoinduction of human osteoblasts via the PI3K/AKT/mTOR/S6K1 signalling pathway. Mol Med Rep. 2019; 19(5):3505-3518. PMC: 6471541. DOI: 10.3892/mmr.2019.10051. View

Zhang C, Peng J, Wu S, Jin Y, Xia F, Wang C . Dioscin promotes osteoblastic proliferation and differentiation via Lrp5 and ER pathway in mouse and human osteoblast-like cell lines. J Biomed Sci. 2014; 21:30. PMC: 4014146. DOI: 10.1186/1423-0127-21-30. View

Qi P, Lv J, Yan X, Bai L, Zhang L . Microfluidics: Insights into Intestinal Microorganisms. Microorganisms. 2023; 11(5). PMC: 10223655. DOI: 10.3390/microorganisms11051134. View

10.

Lin L, Zhang K, Xiong Q, Zhang J, Cai B, Huang Z . Gut microbiota in pre-clinical rheumatoid arthritis: From pathogenesis to preventing progression. J Autoimmun. 2023; 141:103001. DOI: 10.1016/j.jaut.2023.103001. View

11.

Watts N, Bilezikian J, Camacho P, Greenspan S, Harris S, Hodgson S . American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract. 2011; 16 Suppl 3:1-37. PMC: 4876714. DOI: 10.4158/ep.16.s3.1. View

12.

Macpherson A, Harris N . Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol. 2004; 4(6):478-85. DOI: 10.1038/nri1373. View

13.

Zhu L, Hua F, Ding W, Ding K, Zhang Y, Xu C . The correlation between the Th17/Treg cell balance and bone health. Immun Ageing. 2020; 17:30. PMC: 7557094. DOI: 10.1186/s12979-020-00202-z. View

14.

Ohlsson C, Sjogren K . Effects of the gut microbiota on bone mass. Trends Endocrinol Metab. 2014; 26(2):69-74. DOI: 10.1016/j.tem.2014.11.004. View

15.

Dixit M, Singh K, Prakash R, Singh D . Functional block of IL-17 cytokine promotes bone healing by augmenting FOXO1 and ATF4 activity in cortical bone defect model. Osteoporos Int. 2017; 28(7):2207-2220. DOI: 10.1007/s00198-017-4012-5. View

16.

Bhadricha H, Patel V, Singh A, Savardekar L, Patil A, Surve S . Increased frequency of Th17 cells and IL-17 levels are associated with low bone mineral density in postmenopausal women. Sci Rep. 2021; 11(1):16155. PMC: 8352954. DOI: 10.1038/s41598-021-95640-0. View

17.

Chen B, Ye D, Luo L, Liu W, Peng K, Shu X . Adhesive Bacteria in the Terminal Ileum of Children Correlates With Increasing Th17 Cell Activation. Front Pharmacol. 2021; 11:588560. PMC: 7774322. DOI: 10.3389/fphar.2020.588560. View

18.

Otani T, Furuse M . Tight Junction Structure and Function Revisited. Trends Cell Biol. 2020; 30(10):805-817. DOI: 10.1016/j.tcb.2020.08.004. View

19.

Lina C, Conghua W, Nan L, Ping Z . Combined treatment of etanercept and MTX reverses Th1/Th2, Th17/Treg imbalance in patients with rheumatoid arthritis. J Clin Immunol. 2011; 31(4):596-605. DOI: 10.1007/s10875-011-9542-6. View

20.

Macdonald T, Monteleone G . Immunity, inflammation, and allergy in the gut. Science. 2005; 307(5717):1920-5. DOI: 10.1126/science.1106442. View